GenomeUP is a Rome-based healthtech startup aimed at revolutionizing genetic analysis and clinical decision-making. As a global reference platform, GenomeUP provides AI-powered solutions for hospitals, laboratories, research centers, and pharmaceuticals to accelerate diagnosis times and enhance patient care. Their mission is to offer knowledge for health prevention in less than 24 hours.

Acting responsibly and transparently, GenomeUP is a benefit corporation that prioritizes the well-being of people, communities, and stakeholders. They are the proud licensor of JuliaOmix™, a groundbreaking solution designed to streamline the daily disease management workflow for physicians and genetics biologists. This innovative approach to patient diagnosis aims to bring standardization to the field.

GenomeUP prioritizes quality and security, holding certifications such as ISO 9001, ISO 27001, ISO 27017, ISO 27018, and ISO 13485 by Bureau Veritas S. p. a.

They are also qualified as a service provider of SaaS for The Agenzia per l’Italia Digitale – Agency for Digital Italy (AgID). With GenomeUP, the future of genetic analysis and clinical decision support is now within reach